Agilent, Premier Combine Technologies for Glycomics Research | GenomeWeb

NEW YORK (GenomeWeb) – Certain Agilent Technologies mass spectrometers and liquid chromatography instruments now support Premier Biosoft's SimGlycan glycomics software as part of a deal announced today.

"Agilent and Premier Biosoft are focused on solving the glycan and glycopeptides identification problem in biopharmaceutical analyses," Premier Biosoft CEO Arun Apte said in a statement. "Combining our powerful instruments and software will enable researchers to generate, process, and analyze highly complex data so they can put it to use in drug development."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.